|
Market Closed -
Nasdaq
16:00:00 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 52.46 USD | -0.25% |
|
+6.47% | +32.61% |
| 09-02 | Needham Raises Price Target on AtriCure to $64 From $45, Keeps Buy Rating | MT |
| 08-26 | Atricure Insider Sold Shares Worth $458,099, According to a Recent SEC Filing | MT |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 51.67 | -1.76% | 9 | ||||||
| 120.2 | +8.81% | 25 | ||||||
| 103.44 | +12.22% | 25 | ||||||
| 369.31 | +9.8% | 13 | ||||||
| 30,666.67 | +25.58% | 15 | ||||||
| 195.67 | +4.34% | 12 | ||||||
| 94.12 | +4.94% | 25 | ||||||
| 44.6 | +22.86% | 25 | ||||||
| 404.73 | +18.13% | 15 | ||||||
| 3,133.08 | +26.9% | 13 | ||||||
| 263.12 | +14.23% | 8 | ||||||
| 233.36 | +17.92% | 14 | ||||||
| 107.57 | +8.11% | 21 | ||||||
| 93.92 | +2.2% | 13 | ||||||
| 42.95 | -3.71% | 11 | ||||||
| 28.73 | +11.78% | 11 | ||||||
| 208.6 | +31.07% | 15 | ||||||
| 103.23 | +27.98% | 13 | ||||||
| 171.91 | +16.04% | 22 | ||||||
| 329 | -15.32% | 5 | ||||||
| Average | 1,838.29 | +12.11% | 16 | ||||||
| Weighted average by Cap. | 2,369.97 | +12.00% | 19 |
- Stock Market
- Stocks
- ATRC Stock
- Sector AtriCure, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
